Allergene Ai therapeutics

NEXT-GEN IN VIVO CELLULAR IMMUNOTHERAPY

AllerGene AI is pioneering advanced therapeutic solutions through cutting-edge genomic intelligence and cellular engineering.

EXPLORE PIPELINE

OUR TECHNOLOGY

[ MISSION ]

Revolutionizing Cellular Immunotherapy Through Precision AI.

At AllerGene AI Therapeutics, we are pioneering the next generation of in vivo cellular therapies. By integrating advanced biomedical engineering with predictive clinical modeling, we address the most complex therapeutic challenges in immunological disease management.

Therapeutic Solutions

Advancing precision medicine through cellular engineering.

[ 01 ]

In Vivo Cell Therapy

Reprogramming immune cells directly within the patient body to eliminate the need for complex ex vivo processing and reduce treatment timelines.

Learn More

[ 02 ]

Next-Gen Gene Delivery

Developing proprietary viral and non-viral vectors for highly targeted delivery of genetic payloads to specific tissues and cellular populations.

View Research

[ 03 ]

AI-Driven Discovery

Leveraging advanced algorithms to predict therapeutic efficacy and safety profiles, accelerating the path from bench to clinical trials.

AI-Driven Molecular Precision

[01] Advanced predictive algorithms for non-invasive delivery systems.

[02] Real-time cellular response mapping using proprietary AI bio-models.

[03] Accelerated therapeutic discovery through machine learning integration.

Pioneering the Future of Precision Immunotherapy

[ 02 ] OUR EXPERTISE

We leverage cutting-edge AI to architect programmable cellular therapies that precisely target disease at the molecular level. Our unique in vivo platform eliminates the complexities of traditional manufacturing, delivering curative potential directly to the patient.

[ AI ARCHITECTURE ]

99.8% Targeted Precision

[ CLINICAL VELOCITY ]

4x Faster Deployment

Precision automated cellular reprogramming at the AllerGene AI Foundry.